Browsing publications by Julian Leathart

Newcastle AuthorsTitleYear
Dr Quentin Anstee
Dr Rebecca Darlay
Julian Leathart
Yilei Liu
Professor Alastair Burt
et al.
A candidate-gene approach to validation of genetic modifier associations using a large cohort with histologically characterised non-alcoholic fatty liver disease2013
Dr Patrick Kesteven
Julian Leathart
Professor Ann Daly
Professor Farhad Kamali
A Randomized Trial of Genotype-Guided Dosing of Warfarin2013
Dr Quentin Anstee
Dr Rebecca Darlay
Julian Leathart
Dr Helen Reeves
Professor Alastair Burt
et al.
Genome-Wide Association Analysis Confirms Importance of PNPLA3 and Identifies Novel Variants Associated With Histologically Progressive Steatohepatitis in NAFLD2012
Ahmad Alserri
Dr Quentin Anstee
Julian Leathart
Julia Patch
Professor Chris Day
et al.
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies2012
Dr Tina Biss
Dr Peter Avery
Julian Leathart
Professor Farhad Kamali
VKORC1 and CYP2C9 genotype is associated with over-anticoagulation during initiation of warfarin therapy in children2012
Dr Tina Biss
Dr Peter Avery
Julian Leathart
Professor Farhad Kamali
Warfarin dose prediction in children using pharmacogenetics information2012
Dr Tina Biss
Dr Peter Avery
Julian Leathart
Dr John Hanley
Professor Ann Daly
et al.
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children2011
Dr Gul Ozhan
Rajiv Lochan Jayadeva
Julian Leathart
Richard Charnley
Professor Ann Daly
et al.
Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibility2011
Julian Leathart
Professor Ann Daly
Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon(R) probes2011
Dr Nimantha De Alwis
Julian Leathart
Dr Gavin Hudson
Dr Angela Pyle
Dr Catherine Mowbray
et al.
Mitochondrial DNA does not contribute to the heritability of non-alcoholic fatty liver disease2011
12345